Benlysta News
Most Popular Benlysta Story
Benlysta - FDA's Top 10 Blockbuster Decisions
The drug: BenlystaThe partners: Human Genome Sciences and GlaxoSmithKlinePDUFA date: December 9Market potential: $3 billion-$4 billion plus By the time the FDA was finished trashing Human Genome Read more...
Latest Headlines
- January 9, 2012
- July 26, 2011
- May 20, 2011
- March 10, 2011
- December 6, 2010
- November 22, 2010
- November 16, 2010
- November 16, 2010
- November 15, 2010
- November 12, 2010
- October 11, 2010
- April 20, 2010
- November 30, 2009
- November 2, 2009
Paid Research Reports
- Trends in mHealth and Telemedicine
- The Global Aesthetic Dermatology Market Outlook
- Future Directions in Regenerative Medicine
- Pipeline Insight: Insulin Antidiabetics – Novel analogs show promise as alternative delivery methods prove less attractive
- Pipeline Insight: Non-insulin Antidiabetics - Rise of the weight-reducers: Once-weekly GLP-1 agonists and novel SGLT-2 inhibitor
- Forecast Insight: Antidiabetics - Diabetes market growth driven by epidemiological trends and rich pipeline
